Andrea K Graham1,2, Carolyn J Greene3, Mary J Kwasny1,4, Susan M Kaiser1,4, Paul Lieponis5, Thomas Powell6, David C Mohr1,4. 1. Center for Behavioral Intervention Technologies, Northwestern University, Chicago, Illinois. 2. Department of Medical Social Sciences, Northwestern University, Chicago, Illinois. 3. Psychiatric Research Institute, University of Arkansas for Medical Sciences, Little Rock. 4. Department of Preventive Medicine, Northwestern University, Chicago, Illinois. 5. Actualize Therapy, Inc, Chicago, Illinois. 6. Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock.
Abstract
Importance: Depression and anxiety are common and disabling. Primary care is the de facto site for treating these mental health problems but is typically underresourced to meet the burden of these demands. Objective: To evaluate the efficacy of a mobile intervention platform, IntelliCare, for addressing depression and anxiety among primary care patients. Design, Setting, and Participants: Two-arm randomized clinical trial at internal medicine clinics at the University of Arkansas for Medical Sciences. Adult primary care patients (N = 146) who screened positive for depression on the Patient Health Questionnaire-8 (PHQ; score ≥ 10) or anxiety on the Generalized Anxiety Disorder-7 (GAD-7; score ≥ 8) were recruited between July 17, 2018, and December 14, 2018. Interventions: The coach-supported platform composed of a suite of apps, was delivered over 8 weeks. Wait list control participants received treatment as usual for 8 weeks, then the mobile platform. Main Outcomes and Measures: Primary outcomes were changes in depression (PHQ-9) and anxiety (GAD-7) during the intervention period. Secondary outcomes were differences in the proportion of patients who achieved recovery (PHQ-9/GAD-7 <5 or 50% improvement from baseline), sustainment of intervention effects during 2-month follow-up, and app use during the intervention period. Results: One hundred forty-six patients were included (119 of 146 were women [81.5%]; mean [SD] age, 42.3 [13.8] years). Of the 146 patients, 122 (83.6%) were diagnosed as having depression and 131 (89.7%) were diagnosed as having anxiety. A greater proportion of intervention vs wait list control participants achieved recovery from depression (n = 38 of 64 [59%] vs n = 18 of 58 [31%]; odds ratio, 3.25; 95% CI, 1.54-6.86) and anxiety (n = 37 of 65 [57%] vs n = 25 of 66 [38%]; odds ratio, 2.17; 95% CI, 1.08-4.36). Sustained effects were observed for depression (slope, 0.01; 95% CI, -0.09 to 0.10; P = .92) and anxiety scores (slope, 0.02; 95% CI, -0.08 to 0.12; P = .67) during follow-up. App use was high, with a median of 93 and 98 sessions among participants with depression and anxiety, respectively. Conclusions and Relevance: In this trial, a mobile intervention app was effective for depression and anxiety among primary care patients. Findings also support designing digital mental health interventions as platforms containing simple, brief apps that can be bundled by users to meet their needs. Trial Registration: ClinicalTrials.gov Identifier: NCT03500536.
Importance: Depression and anxiety are common and disabling. Primary care is the de facto site for treating these mental health problems but is typically underresourced to meet the burden of these demands. Objective: To evaluate the efficacy of a mobile intervention platform, IntelliCare, for addressing depression and anxiety among primary care patients. Design, Setting, and Participants: Two-arm randomized clinical trial at internal medicine clinics at the University of Arkansas for Medical Sciences. Adult primary care patients (N = 146) who screened positive for depression on the Patient Health Questionnaire-8 (PHQ; score ≥ 10) or anxiety on the Generalized Anxiety Disorder-7 (GAD-7; score ≥ 8) were recruited between July 17, 2018, and December 14, 2018. Interventions: The coach-supported platform composed of a suite of apps, was delivered over 8 weeks. Wait list control participants received treatment as usual for 8 weeks, then the mobile platform. Main Outcomes and Measures: Primary outcomes were changes in depression (PHQ-9) and anxiety (GAD-7) during the intervention period. Secondary outcomes were differences in the proportion of patients who achieved recovery (PHQ-9/GAD-7 <5 or 50% improvement from baseline), sustainment of intervention effects during 2-month follow-up, and app use during the intervention period. Results: One hundred forty-six patients were included (119 of 146 were women [81.5%]; mean [SD] age, 42.3 [13.8] years). Of the 146 patients, 122 (83.6%) were diagnosed as having depression and 131 (89.7%) were diagnosed as having anxiety. A greater proportion of intervention vs wait list control participants achieved recovery from depression (n = 38 of 64 [59%] vs n = 18 of 58 [31%]; odds ratio, 3.25; 95% CI, 1.54-6.86) and anxiety (n = 37 of 65 [57%] vs n = 25 of 66 [38%]; odds ratio, 2.17; 95% CI, 1.08-4.36). Sustained effects were observed for depression (slope, 0.01; 95% CI, -0.09 to 0.10; P = .92) and anxiety scores (slope, 0.02; 95% CI, -0.08 to 0.12; P = .67) during follow-up. App use was high, with a median of 93 and 98 sessions among participants with depression and anxiety, respectively. Conclusions and Relevance: In this trial, a mobile intervention app was effective for depression and anxiety among primary care patients. Findings also support designing digital mental health interventions as platforms containing simple, brief apps that can be bundled by users to meet their needs. Trial Registration: ClinicalTrials.gov Identifier: NCT03500536.
Authors: Kelly Posner; Gregory K Brown; Barbara Stanley; David A Brent; Kseniya V Yershova; Maria A Oquendo; Glenn W Currier; Glenn A Melvin; Laurence Greenhill; Sa Shen; J John Mann Journal: Am J Psychiatry Date: 2011-12 Impact factor: 18.112
Authors: Simon Gilbody; Sally Brabyn; Karina Lovell; David Kessler; Thomas Devlin; Lucy Smith; Ricardo Araya; Michael Barkham; Peter Bower; Cindy Cooper; Sarah Knowles; Elizabeth Littlewood; David A Richards; Debbie Tallon; David White; Gillian Worthy Journal: Br J Psychiatry Date: 2017-03-02 Impact factor: 9.319
Authors: Andrea K Graham; Carolyn J Greene; Thomas Powell; Pauli Lieponis; Amanda Lunsford; Chris D Peralta; L Casey Orr; Susan M Kaiser; Nameyeh Alam; Helom Berhane; Ozan Kalan; David C Mohr Journal: Transl Behav Med Date: 2020-08-07 Impact factor: 3.046
Authors: Deborah S Hasin; Aaron L Sarvet; Jacquelyn L Meyers; Tulshi D Saha; W June Ruan; Malka Stohl; Bridget F Grant Journal: JAMA Psychiatry Date: 2018-04-01 Impact factor: 21.596
Authors: David H Barlow; Todd J Farchione; Jacqueline R Bullis; Matthew W Gallagher; Heather Murray-Latin; Shannon Sauer-Zavala; Kate H Bentley; Johanna Thompson-Hollands; Laren R Conklin; James F Boswell; Amantia Ametaj; Jenna R Carl; Hannah T Boettcher; Clair Cassiello-Robbins Journal: JAMA Psychiatry Date: 2017-09-01 Impact factor: 21.596
Authors: Liesje Donkin; Helen Christensen; Sharon L Naismith; Bruce Neal; Ian B Hickie; Nick Glozier Journal: J Med Internet Res Date: 2011-08-05 Impact factor: 5.428
Authors: Anna Dt Muntingh; Christina M van der Feltz-Cornelis; Harm Wj van Marwijk; Philip Spinhoven; Anton Jlm van Balkom Journal: BMC Fam Pract Date: 2016-06-02 Impact factor: 2.497
Authors: Andrea K Graham; Mary J Kwasny; Emily G Lattie; Carolyn J Greene; Neha V Gupta; Madhu Reddy; David C Mohr Journal: Internet Interv Date: 2021-05-19
Authors: Alexandra Werntz; Alexandra L Silverman; Henry Behan; Suraj K Patel; Miranda Beltzer; Mehdi O Boukhechba; Laura Barnes; Bethany A Teachman Journal: Behav Ther Date: 2021-12-11
Authors: John Torous; Sandra Bucci; Imogen H Bell; Lars V Kessing; Maria Faurholt-Jepsen; Pauline Whelan; Andre F Carvalho; Matcheri Keshavan; Jake Linardon; Joseph Firth Journal: World Psychiatry Date: 2021-10 Impact factor: 49.548
Authors: David C Mohr; Francisca Azocar; Andrew Bertagnolli; Tanzeem Choudhury; Paul Chrisp; Richard Frank; Henry Harbin; Trina Histon; Debra Kaysen; Camille Nebeker; Derek Richards; Stephen M Schueller; Nickolai Titov; John Torous; Patricia A Areán Journal: Psychiatr Serv Date: 2021-01-20 Impact factor: 4.157
Authors: Judith Borghouts; Elizabeth Eikey; Gloria Mark; Cinthia De Leon; Stephen M Schueller; Margaret Schneider; Nicole Stadnick; Kai Zheng; Dana Mukamel; Dara H Sorkin Journal: J Med Internet Res Date: 2021-03-24 Impact factor: 5.428